• 7023 malaria professionals are enjoying the free benefits of MalariaWorld today

medicine

Is parasite clearance clinically important after malaria treatment in a high transmission area? A 3-month follow-up of home-based management with herbal medicine or ACT

Author(s): 
Merlin L. Willcox, Bertrand Graz, Chiaka Diakite, Jacques Falquet, Florent Dackouo, Oumar Sidibe, Sergio Giani, Drissa Diallo
Reference: 
Transactions of the Royal Society of Tropical Medicine and Hygiene, Volume 105, Issue 1, January 2011, Pages 23-31

This study, in a high transmission area of South Mali, explores whether residual parasitaemia at day 28 was associated with subsequent malaria episodes and/or anaemia.

Open Access | Oral Presentation: Refreshed approaches to the therapy of malaria - the case of natural medicine

Author(s): 
Hagai Ginsburg
Reference: 
Malaria Journal 2010, 9(Suppl 2):O16 (20 October 2010)
Contact email: 
hagai.ginsburg@GMAIL.COM

This disappointment and the successful use of natural compounds emerging from traditional medicine for the chemotherapy of malaria (quinine, artemisnin) have invigorated the search for new antimalarials from natural sources. Hundreds of thousands compounds were screened and some promising leads were identified.

Open Access | Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya

Author(s): 
Rowa Y, Abuya TO, Mutemi WK, Ochola S, Molyneux C, Marsh V
Reference: 
BMC Public Health 2010, 10:93 (24 February 2010)

This study explored stakeholders' perceptions of the role of private medicine retailers (PMRs), the value and feasibility of programme goals, perceived programme impact, factors influencing implementation and recommendations in three districts of Kenya.

Review: New medicines to improve control and contribute to the eradication of malaria

Author(s): 
Timothy N. C. Wells, Pedro L. Alonso & Winston E. Gutteridge
Reference: 
Nature Reviews Drug Discovery 8, 879-891 (November 2009)
Contact email: 
wellst@mmv.org

Recent advances in genome-based technologies and in in vitro screening of whole parasites have broadened the range of therapeutic targets and are accelerating the development of a new generation of treatments for both malaria control and eradication.

Syndicate content